Corcept Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $167.9M | $167.4M | $469.0K | $42.9M |
| FY2022 | $120.3M | $119.9M | $413.0K | $42.4M |
| FY2023 | $126.7M | $126.5M | $139.0K | $48.9M |
| FY2024 | $198.3M | $196.1M | $2.2M | $61.4M |
| FY2025 | $142.0M | $141.8M | $211.0K | $84.5M |